GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Additional Paid-In Capital

3SBio, (FRA:YFK) Additional Paid-In Capital : €598.4 Mil(As of Dec. 2016)


View and export this data going back to . Start your Free Trial

What is 3SBio, Additional Paid-In Capital?


3SBio,'s quarterly additional paid-in capital declined from Dec. 2015 (€620.0 Mil) to Jun. 2016 (€589.9 Mil) but then increased from Jun. 2016 (€589.9 Mil) to Dec. 2016 (€598.4 Mil).

3SBio,'s annual additional paid-in capital increased from Dec. 2014 (€67.8 Mil) to Dec. 2015 (€620.0 Mil) but then declined from Dec. 2015 (€620.0 Mil) to Dec. 2016 (€598.4 Mil).

3SBio, Additional Paid-In Capital Historical Data

The historical data trend for 3SBio,'s Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Additional Paid-In Capital Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 116.51 121.90 67.76 619.96 598.37

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.76 649.83 619.96 589.95 598.37

3SBio, Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

3SBio, Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio, (FRA:YFK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Additional Paid-In Capital
Comparable Companies
RFL ROCO:3176 APLT CABA SRRK GRTX OSMT UBX TPE:4142 GRTS OYST SZSE:002286 CRBP TSE:7774 ROCO:6712 SZSE:002868 CDMO SZSE:002898 UROV KIN
Traded in Other Exchanges
N/A
Address
Website
http://www.3sbio.com
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines